AI English summary of an SEC filing — figures as filed
The company said its consolidated total revenue (GAAP) including GE Vernova was $16.1B (+11%) for Q1 2024, and GE Vernova was separated through a spin-off after quarter-end on April 2, 2024.
Key points
AI summaryThe company said its consolidated total revenue (GAAP) including GE Vernova was $16.1B (+11%) for Q1 2024, and GE Vernova was separated through a spin-off after quarter-end on April 2, 2024.
The company said GE Aerospace standalone adjusted revenue was $8.1 billion (+15%) for Q1 2024, operating profit was $1.5 billion (+24%), and operating profit margin was 19.1% (+140 basis points).
GE Aerospace said it expects full-year 2024 operating profit of $6.2B to $6.6B (March 2024 outlook: $6.0B to $6.5B), adjusted EPS of $3.80 to $4.05, and free cash flow of more than $5B, or more than 100% conversion.
GE said it received $2.6 billion in Q1 2024 from monetizing part of its GE HealthCare shares, and that it repurchased approximately 1.1 million common shares for $0.1 billion under its previously authorized $3 billion share repurchase program.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
GE Consolidated Results and GE Vernova Spin-Off
The company said its consolidated total revenue (GAAP) including GE Vernova was $16.1B (+11%) for Q1 2024, and GE Vernova was separated through a spin-off after quarter-end on April 2, 2024.
Source · Based on the filing body and exhibits
GE Aerospace Standalone Results for Q1
The company said GE Aerospace standalone adjusted revenue was $8.1 billion (+15%) for Q1 2024, operating profit was $1.5 billion (+24%), and operating profit margin was 19.1% (+140 basis points).
Source · Based on the filing body and exhibits
GE Aerospace Full-Year 2024 Outlook
GE Aerospace said it expects full-year 2024 operating profit of $6.2B to $6.6B (March 2024 outlook: $6.0B to $6.5B), adjusted EPS of $3.80 to $4.05, and free cash flow of more than $5B, or more than 100% conversion.
Source · Based on the filing body and exhibits
GE HealthCare Stake Monetization and Share Repurchases
GE said it received $2.6 billion in Q1 2024 from monetizing part of its GE HealthCare shares, and that it repurchased approximately 1.1 million common shares for $0.1 billion under its previously authorized $3 billion share repurchase program.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…